Rapamycin Reduces Bax Levels in Alzheimer's Patients
P
Physionic YouTube channel discusses the effects of Rapamycin on Alzheimer's disease.
Story of claim
Rapamycin reduces pro-apoptotic proteins like Bax in Alzheimer's disease models, potentially preventing mitochondrial damage and cell death. This could slow disease progression.
- Goal: To reduce the impact of Alzheimer's by targeting mitochondrial health.
- Proof: Rapamycin decreases Bax protein levels, which are linked to mitochondrial damage in Alzheimer's, potentially mitigating cell death pathways.
- Nuances:
- Doubling in Bax is present in Alzheimer's condition.
- Pro-apoptotic proteins encourage pore formation on mitochondria.
- Impact on Life: Potential reduction in Alzheimer's progression through the mitigation of cell death pathways.
Investments
- Price: Not mentioned
- Time: Research and trials needed for validation.
- Effort: Requires substantial research and clinical trials.
Risks
Potential unknown side effects due to lack of extensive human studies.
Get Started 🚀
- Review current research on Rapamycin and Alzheimer's.
- Consult with a healthcare provider for potential trials.
- Monitor ongoing studies for updates on effectiveness.
Brogevity AI can make mistakes. Check important info.